Lieke Jäkel and Anna de Kort, both PhD students with Marcel Verbeek, and neurologists Floris Schreuder and Karin Klijn performed a systematic review and meta-analysis on the prevalence of Cerebral Amyloid Angiopathy (CAA) in several populations. The study is published in Alzheimers and Dementia, on May 31st 2021.
For the current study, 170 publications were scrutinized and analyzed, comprising publications using either a neuroimaging or a neuropathological approach. CAA is associated with cognitive dysfunction and intracerebral hemorrhage, and linked to immunotherapy-related side-effects in Alzheimer’s disease (AD). Given ongoing efforts to develop AD immunotherapy, accurate estimates of CAA prevalence are important. In this review, it is concluded that prevalence is high in AD (48%) and substantial in the general population (23%) when neuropathological examination is possible. In contrast, however, CAA could only be demonstrated in one third (population) to one half (AD patients) of the subjects when neuroimaging was applied.
This study demonstrates that the prevalence of CAA in the general population and AD is significant, but that current diagnostic techniques fall short in its identification, calling for more sensitive biomarkers for CAA. This is particularly relevant with the very recent conditional approval of anti-amyloid antibody aducanumab for treatment of AD, the side-effects of which are strongly associated with CAA.
Lieke Jäkel, Anna M. De Kort, Catharina J.M. Klijn, Floris H.B.M. Schreuder, Marcel M. Verbeek. Prevalence of cerebral amyloid angiopathy: A systematic review and meta-analysis (2021), Alzheimer’s and Dementia.
Related news items
The international dataset for colorectal local excisions is published16 June 2021
Iris Nagtegaal and colleagues presented their first paper on the colorectal cancer dataset and published this in the journal Gastroenterology.read more
Neuraminidase and SIGLEC15 modulate the host defense against pulmonary aspergillosis15 June 2021
Intan Dewi and Frank van de Veerdonk published in Cell Reports Medicine that Neuraminidase and SIGLEC15 modulate the host defense against pulmonary aspergillosis.read more
ZonMw Open Competition Grants for several Radboud researchers15 June 2021
Four teams including researchers from Radboudumc and Radboud University receive a ZonMw Open Competion grant. Each proposal has a maximum budget of 750K euros.read more
ZonMw Open Competition Grant for Annemiek van Spriel and Piet Gros15 June 2021
Annemiek van Spriel, theme cancer development and immune defense, together with Piet Gros, Dept. of Chemistry, Utrecht University obtained a ZonMw Open Competition Grant to investigate IL-6 receptor structure and signalling in tumor cells.read more